Key pharmaceutical brands produced by Chiesi 2016-2019, by revenues

Foster, Curosurf and Clenil are the key brand name drugs to treat problems of the respiratory area, developed and marketed by the Italian pharmaceutical company Chiesi. In 2019, Foster generated the largest sales revenues, with 812 million euros. Curosurf and Clenil followed far behind with revenues amounting to 229 and 143 million euros, respectively.

Chiesi in the domestic and international market

 Chiesi is among the leading Italian pharmaceutical companies based on revenues, as well as one of the European firms of this sector with the greatest level of investments in research and development. The company established itself on the pharmaceutical market back in 1979, specifically thanks to the launch of Clenil, which is, as above mentioned, still one of its key products.  

Research and development

Nowadays, Chiesi’s focus is within the respiratory area, primary care, neonatology and rare diseases. In addition, the company has recently started to explore the field of regenerative medicine and to develop eco-friendly and innovative products. Their increasing investments in research and development may suggest that innovation plays a key role in Chiesi’s business model.

Key brand name drugs produced by the Italian pharmaceutical company Chiesi from 2016 to 2019, by revenues

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

2020

Region

Italy

Survey time period

2016 to 2019

Supplementary notes

The source adds the following information: “The brand drugs mentioned refers to the respiratory therapeutic class, the one in which Chiesi is a key player at global level”.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Italy"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.